-
R.
Klausner,
A.
Fauci,
L.
Corey,
G.
Nabel,
H.
Gayle
(2003)
The need for a global HIV vaccine enterprise. Policy forum.
Science, 300
-
S.
Dubey,
J.
Clair,
T.
Fu,
L.
Guan,
Romnie
Long,
R.
Mogg,
K.
Anderson,
K.
Collins,
C.
Gaunt,
V.
Fernandez,
Lan
Zhu,
L.
Kierstead,
Scott
Thaler,
Swati
Gupta,
W.
Straus,
D.
Mehrotra,
T.
Tobery,
D.
Casimiro,
J.
Shiver
(2007)
Detection of HIV Vaccine-Induced Cell-Mediated Immunity in HIV-Seronegative Clinical Trial Participants Using an Optimized and Validated Enzyme-Linked Immunospot Assay
JAIDS Journal of Acquired Immune Deficiency Syndromes, 45
-
Jeffrey
Smith,
Heather
Joseph,
T.
Green,
J.
Field,
Melissa
Wooters,
R.
Kaufhold,
J.
Antonello,
M.
Caulfield
(2007)
Establishing Acceptance Criteria for Cell-Mediated-Immunity Assays Using Frozen Peripheral Blood Mononuclear Cells Stored under Optimal and Suboptimal Conditions
Clinical and Vaccine Immunology, 14
-
S.
Janetzki,
K.
Panageas,
L.
Ben-Porat,
J.
Boyer,
C.
Britten,
T.
Clay,
M.
Kalos,
H.
Maecker,
P.
Romero,
Jianda
Yuan,
W.
Kast,
A.
Hoos,
for
Group
(2007)
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
Cancer Immunology, Immunotherapy, 57
-
T.
Tobery,
S.
Dubey,
K.
Anderson,
D.
Freed,
K.
Cox,
Jing
Lin,
Michael
Prokop,
K.
Sykes,
R.
Mogg,
D.
Mehrotra,
T.
Fu,
D.
Casimiro,
J.
Shiver
(2006)
A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjects.
AIDS research and human retroviruses, 22 11
-
Sylvia
Janetzki,
Susanne
Schaed,
Susanne
Schaed,
Nathalie
Blachere,
Nathalie
Blachere,
Leah
Ben-Porat,
Alan
Houghton,
K.
Panageas
(2004)
Evaluation of Elispot assays: influence of method and operator on variability of results.
Journal of immunological methods, 291 1-2
-
M.
D’Souza,
M.
Altfeld
(2008)
Measuring HIV-1-specific T cell immunity: how valid are current assays?
The Journal of infectious diseases, 197 3
-
A.
Malyguine,
S.
Strobl,
K.
Shafer-Weaver,
Tracy
Ulderich,
Angela
Troke,
M.
Baseler,
L.
Kwak,
S.
Neelapu
(2004)
A modified human ELISPOT assay to detect specific responses to primary tumor cell targets
Journal of Translational Medicine, 2
-
T.
Whiteside,
Y.
Zhao,
T.
Tsukishiro,
E.
Elder,
W.
Gooding,
J.
Baar
(2003)
Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research, 9 2
-
M.
McElrath,
Robert
Siliciano,
Kent
Weinhold
(1997)
HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization, and quantitation.
AIDS research and human retroviruses, 13 3
-
J.
Cox,
G.
Ferrari,
Spyros
Kalams,
W.
Lopaczynski,
N.
Oden,
M.
D’Souza
(2005)
Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials.
AIDS research and human retroviruses, 21 1
-
M.
Disis,
C.
Rosa,
V.
Goodell,
Ling-Yu
Kuan,
Jennie
Chang,
K.
Kuus-Reichel,
T.
Clay,
H.
Lyerly,
Sonny
Bhatia,
S.
Ghanekar,
V.
Maino,
H.
Maecker
(2001)
Maximizing the Retention of Antigen Specific Lymphocyte Function after Cryopreservation
-
R.
Koup,
J.
Safrit,
Yun-zhen
Cao,
C.
Andrews,
G.
McLeod,
W.
Borkowsky,
C.
Farthing,
D.
Ho
(1994)
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
Journal of Virology, 68
-
H.
Maecker,
J.
Moon,
Sonny
Bhatia,
S.
Ghanekar,
V.
Maino,
Janice
Payne,
Kristine
Kuus-Reichel,
Jennie
Chang,
Amanda
Summers,
T.
Clay,
Michael
Morse,
H.
Lyerly,
Corazon
Delarosa,
Donna
Ankerst,
Mary
Disis
(2005)
Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT
BMC Immunology, 6
-
N.
Russell,
M.
Hudgens,
Richard
Ha,
C.
Havenar-Daughton,
M.
McElrath
(2003)
Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity.
The Journal of infectious diseases, 187 2
-
R.
Klausner,
A.
Fauci,
L.
Corey,
Lawrence
Corey,
G.
Nabel,
H.
Gayle,
S.
Berkley,
B.
Haynes,
D.
Baltimore,
C.
Collins,
R.
Douglas,
J.
Esparza,
D.
Francis,
N.
Ganguly,
J.
Gerberding,
M.
Johnston,
M.
Kazatchkine,
A.
McMichael,
M.
Makgoba,
G.
Pantaleo,
P.
Piot,
Y.
Shao,
E.
Tramont,
H.
Varmus,
J.
Wasserheit
(2003)
Enhanced: The Need for a Global HIV Vaccine Enterprise
Science, 300
-
R.
Sékaly
(2008)
The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
The Journal of Experimental Medicine, 205
-
L.
Nomura,
Joshua
Walker,
H.
Maecker
(2000)
Optimization of whole blood antigen-specific cytokine assays for CD4(+) T cells.
Cytometry, 40 1
-
M.
Mwau,
A.
McMichael,
T.
Hanke
(2002)
Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines.
AIDS research and human retroviruses, 18 9
-
H.
Maecker,
Jeffrey
Hassler,
J.
Payne,
Amanda
Summers,
Karrie
Comatas,
M.
Ghanayem,
M.
Morse,
T.
Clay,
H.
Lyerly,
Sonny
Bhatia,
S.
Ghanekar,
V.
Maino,
Corazon
Delarosa,
M.
Disis
(2008)
Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides
BMC Immunology, 9
-
B.
Peters,
W.
Jaoko,
E.
Vardas,
George
Panayotakopoulos,
P.
Fast,
C.
Schmidt,
J.
Gilmour,
M.
Bogoshi,
G.
Omosa-Manyonyi,
L.
Dally,
L.
Klavinskis,
B.
Farah,
T.
Tarragona,
P.
Bart,
A.
Robinson,
Colleen
Pieterse,
W.
Stevens,
R.
Thomas,
B.
Barin,
A.
McMichael,
J.
McIntyre,
G.
Pantaleo,
T.
Hanke,
J.
Bwayo
(2007)
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity.
Vaccine, 25 11
-
(2003)
Good clinical laboratory practice (GCLP). A quality system for laboratories that undertake the analyses of samples from clinical trials
-
J.
Schmitz,
R.
Johnson,
H.
McClure,
K.
Manson,
M.
Wyand,
M.
Kuroda,
M.
Lifton,
Rajinder
Khunkhun,
K.
Mcevers,
J.
Gillis,
M.
Piatak,
J.
Lifson,
Gudrun
Grosschupff,
P.
Rácz,
K.
Tenner‐Racz,
E.
Rieber,
Kristine
Kuus-Reichel,
R.
Gelman,
N.
Letvin,
D.
Montefiori,
R.
Ruprecht,
R.
Desrosiers,
K.
Reimann
(2005)
Effect of CD8+ Lymphocyte Depletion on Virus Containment after Simian Immunodeficiency Virus SIVmac251 Challenge of Live Attenuated SIVmac239Δ3-Vaccinated Rhesus Macaques
Journal of Virology, 79
-
J.
Vuola,
S.
Keating,
D.
Webster,
T.
Berthoud,
Susanna
Dunachie,
S.
Gilbert,
A.
Hill
(2005)
Differential Immunogenicity of Various Heterologous Prime-Boost Vaccine Regimens Using DNA and Viral Vectors in Healthy Volunteers1
The Journal of Immunology, 174
-
J.
Sacha,
C.
Chung,
E.
Rakasz,
S.
Spencer,
A.
Jonas,
Alexander
Bean,
Wonhee
Lee,
B.
Burwitz,
Jason
Stephany,
J.
Loffredo,
D.
Allison,
Sama
Adnan,
A.
Hoji,
N.
Wilson,
T.
Friedrich,
J.
Lifson,
O.
Yang,
D.
Watkins
(2007)
Gag-Specific CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression1
The Journal of Immunology, 178
-
P.
Borrow,
H.
Lewicki,
Xiping
Wei,
M.
Horwitz,
N.
Peffer,
Heather
Meyers,
J.
Nelson,
J.
Gairin,
B.
Hahn,
M.
Oldstone,
G.
Shaw
(1997)
Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
Nature Medicine, 3
-
Xia
Jin,
Daniel
Bauer,
Sarah
Tuttleton,
S.
Lewin,
A.
Gettie,
J.
Blanchard,
C.
Irwin,
J.
Safrit,
J.
Mittler,
L.
Weinberger,
L.
Kostrikis,
Linqi
Zhang,
A.
Perelson,
D.
Ho
(1999)
Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques
The Journal of Experimental Medicine, 189
-
C.
Britten,
S.
Janetzki,
S.
Burg,
C.
Gouttefangeas,
A.
Hoos
(2007)
Toward the harmonization of immune monitoring in clinical trials: Quo vadis?
Cancer Immunology, Immunotherapy, 57
-
J.
Currier,
E.
Kuta,
E.
Turk,
Lyndsay
Earhart,
L.
Loomis-Price,
S.
Janetzki,
G.
Ferrari,
D.
Birx,
J.
Cox
(2002)
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.
Journal of immunological methods, 260 1-2
-
N.
Goonetilleke,
Stephen
Moore,
L.
Dally,
N.
Winstone,
I.
Cebere,
Abdul
Mahmoud,
Susana
Pinheiro,
G.
Gillespie,
Denise
Brown,
Vanessa
Loach,
Joanna
Roberts,
A.
Guimarães-Walker,
P.
Hayes,
K.
Loughran,
Carol
Smith,
J.
Bont,
C.
Verlinde,
Danii
Vooijs,
C.
Schmidt,
Mark
Boaz,
J.
Gilmour,
P.
Fast,
L.
Dorrell,
T.
Hanke,
A.
McMichael
(2006)
Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes
Journal of Virology, 80
-
M.
Betts,
J.
Casazza,
R.
Koup
(2001)
Monitoring HIV-specific CD8+ T cell responses by intracellular cytokine production.
Immunology letters, 79 1-2
-
J.
Sacha,
C.
Chung,
E.
Rakasz,
S.
Spencer,
A.
Jonas,
Alexander
Bean,
Wonhee
Lee,
B.
Burwitz,
Jason
Stephany,
J.
Loffredo,
D.
Allison,
Sama
Adnan,
A.
Hoji,
N.
Wilson,
T.
Friedrich,
J.
Lifson,
O.
Yang,
D.
Watkins
(2007)
Gag-Specific CD 8 T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression 1
-
S.
Fauce,
O.
Yang,
R.
Effros
(2007)
Autologous CD4/CD8 co-culture assay: a physiologically-relevant composite measure of CD8+ T lymphocyte function in HIV-infected persons.
Journal of immunological methods, 327 1-2